Prevention of graft vs. host disease with alemtuzumab 'in the bag' decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome

Author: Novitzky N.   Thomas V.   Toit C du  

Publisher: Ashgate Publishing Ltd

ISSN: 1465-3249

Source: Cytotherapy, Vol.10, Iss.1, 2007-12, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content